---
{"dg-publish":true,"permalink":"/USMLE/Blood/Pure red cell aplasia/"}
---

# Overview
---
- Description: <span style="background:rgba(240, 200, 0, 0.2)">normocytic, normochromic anemia characterized by a severe reduction in circulating reticulocytes and marked reduction or absence of erythroid precursors in the bone marrow</span> 
- Pathophysiology: thought to be related to <span style="background:rgba(240, 200, 0, 0.2)">abnormal T-cell function and IgG antibodies that target erythroblasts and erythropoietin </span>
	- Etiology
		- Acquired
			- Most often idiopathic
			- Possible associated conditions
				- <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/MSK/Thymoma\|Thymoma]]</span>
				- [[USMLE/Blood/Myelodysplastic syndromes\|Myelodysplastic syndrome]]
				- Adverse drugs effects (e.g., from phenytoin, chloramphenicol)
				- [[USMLE/Infective disease/Parvovirus B19\|Parvovirus B19]] infection
				- Autoimmune disorders (e.g., [[USMLE/Endocrine/Diabetes mellitus\|type 1 diabetes]], thyroiditis, [[USMLE/MSK/Rheumatoid arthritis\|rheumatoid arthritis]])
		- <span style="background:rgba(240, 200, 0, 0.2)">Congenital: Diamond-Blackfan anemia (DBA)</span>: see below
- Diagnostics
	- <span style="background:rgba(240, 200, 0, 0.2)">Low reticulocyte count</span>
	- <span style="background:rgba(240, 200, 0, 0.2)">Bone marrow biopsy shows marked reduction or absence of erythroid precursors.</span>
- Treatment
	- Treatment of the underlying cause (e.g., cessation of possible offending agents, thymectomy)
	- Red blood cell [[USMLE/Blood/Transfusion\|transfusion]] for symptomatic patients
	- Immunosuppressive and/or cytotoxic agents (e.g., glucocorticoids, cyclosporine, cyclophosphamide)
# Diamond-Blackfan anemia
---
- Description
	- <span style="background:rgba(240, 200, 0, 0.2)">Intrinsic defect of erythroid progenitor cells → ↑ apoptosis</span>
	- Usually autosomal dominant inheritance or associated with impaired ribosome synthesis mutations
	- <span style="background:rgba(240, 200, 0, 0.2)">Rapid onset of macrocytic (nonmegaloblastic) anemia in infancy (usually diagnosed within the first year of life)</span>
- Additional clinical features: physical abnormalities manifest in ∼50% of affected individuals
	- Fatigue, poor feeding
	- <span style="background:rgba(240, 200, 0, 0.2)">Short stature</span>, webbed neck
	- <span style="background:rgba(240, 200, 0, 0.2)">Upper extremity malformations (e.g., triphalangeal thumbs) </span>![Pasted image 20250131213723.png](/img/user/appendix/Pasted%20image%2020250131213723.png)
	- Microcephaly, micrognathia
	- Hypertelorism, flat nasal bridge, [[USMLE/Reproductive/Cleft lip and cleft palate\|cleft palate]]
	- Congenital [[USMLE/Neurology/Cataract\|cataracts]] or [[USMLE/Neurology/Glaucoma\|glaucoma]]
	- Atrial and ventricular septal defects
- Diagnostics
	- Electrophoresis
		- <span style="background:rgba(240, 200, 0, 0.2)">Elevated HbF levels</span>
		- Low total Hb levels
	- Specific laboratory findings
		- Elevated erythrocyte [[USMLE/Pharmacology/Antiarrhythmic drugs\|adenosine]] deaminase levels (eADA)
		- Increased expression of i antigen in RBCs
